Cresco advises Aminolabs Nutrition on its strategic acquisition of Zoka Pharma

Cresco is proud to have assisted Aminolabs Nutrition, a leading developer and manufacturer of innovative sports and nutritional supplements, in its strategic acquisition of ZOKA PHARMA.

Aminolabs Nutrition, headquartered in Belgium, partners with global brands to create, develop and produce nutritional supplements, sports nutrition and functional food, offering science-based, tailor-made solutions to help their customers succeed in an increasingly competitive market.

ZOKA PHARMA, based in Spain, is known for its strong expertise in the research, development and production of innovative, high-quality nutraceuticals and dietary supplements for health-conscious consumers across Europe.

This landmark transaction marks an important step in Aminolabs’ growth journey and strengthens its presence and capabilities in the European market.

The Cresco-team involved in this transaction consisted of Glenn L’hoëst and Rutger Duden.

Congratulations to the Aminolabs-team on this exiting next step!

We sincerely thank Vincent Vanhooymissen, Roger Anné and Ancy Mangelschots (Aminolabs Nutrition), Dominique Roux, Charlotte Poelmans and Jeffry Van den Heuvel (LRM NV), Charles Lanceley and Dominic Barnes (Alantra) and Felipe Pineda and Sergi Giménez Binder (Augusta Abogados) for the excellent collaboration throughout this transaction.

For more information, please visit De Tijd.

For any further information or questions, feel free to contact Glenn L’hoëst.

logo Aminolabs

Team

Glenn L'hoëst
Partner
Rutger Duden
Associate

Expertises

corporate
mergers & acquisitions